Don't want ads? Subscribe or login now.

Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says

By Ben Zigterman · January 23, 2024, 7:54 PM EST

The liquidation trustee of Insys Therapeutics on Tuesday asked a Delaware bankruptcy judge for an injunction preventing the pharmaceutical company's former CEO Michael L. Babich from pursuing counterclaims in a clawback...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Insys Therapeutics, Inc.

Case Number

1:19-bk-11292

Court

Delaware

Nature of Suit

Date Filed

June 10, 2019

Recent Articles By Ben

April 22, 2024
Ebix Can Use Proceeds Of $386M Sale To Pay Down Debt
April 09, 2024
Ch. 11 Judge Tosses Calif. Drug Co.'s Bid To Stay Investor Suit
February 13, 2024
Kidde-Fenwal Row Not For Bankruptcy Court, Insurers Say
February 05, 2024
Zymergen Ch. 11 Plan Confirmed After Investor Objection
January 25, 2024
Eye Care Tech Co. Gets Tentative OK For $8M DIP
January 10, 2024
Celsius Insurers Seek OK To Pay Execs' Defense Costs
December 01, 2023
LA Airports' Bid For COVID Coverage Sunk By Federal Judge
November 13, 2023
Kidde-Fenwal Seeks Insurance Coverage For Foam Claims
November 02, 2023
3rd Circ. Rejects Bids To Freeze Boy Scouts' Ch. 11 Plan
October 31, 2023
Adjuster Wants Out Of Apartment's Ida Damage Coverage Suit